In the News June 2013
-Gene patents decision: Everybody wins
Inside Stanford Medicine
Court's decision likely good for patients, experts say
This piece discusses the Supreme Court’s recent decision on gene patenting and features Hank Greely, with the Stanford Center for Biomedical Ethics (SCBE). An Inside Stanford Medicine story also delves into the ruling and what it means for patient care; Greely; Douglas Blayney, the Ann and John Doerr Medical Director of the Stanford Cancer Institute and professor of medicine at the school; Mark Pegram, the Susy Yuan-Huey Hung Professor; Mildred Cho, professor of pediatrics and associate director of the SCBE; Michael Snyder, the Stanford W. Ascherman, MD, FACS, Professor in Genetics and director of Stanford's Center for Genomics and Personalized Medicine; Atul Butte, associate professor of pediatrics and of genetics; and Christopher Scott, senior research scholar in the SCBE and director of Stanford's Program on Stem Cells in Society, are all featured.
--Independent Lens (PBS)
Documentary by filmmakers at medical school to air on KQED on June 17
The Revolutionary Optimists, a documentary co-directed and co-produced by Maren Grainger-Monsen and Nicole Newnham, will air on the Emmy Award-winning series Independent Lens, hosted by Stanley Tucci, tonight at 10 p.m. on KQED. Grainger-Monsen is founder and director of the Program in Bioethics in Film at the Stanford Center for Biomedical Ethics. Newnham is an independent documentary filmmaker, currently a filmmaker-in-residence with the program.
--7 takeaways from Supreme Court's gene patent decision
This piece discusses the Supreme Court’s recent decision on gene patenting and what it means for patients and the biotech industry. Hank Greely, with the Stanford Center for Biomedical Ethics, is featured here.
This segment discussed the Supreme Court’s decision on gene patenting. Mildred Cho, professor of pediatrics and associate director of the SCBE, talked about the decision and its implications.
Los Angeles Times
--Researchers hail Supreme Court decision on gene patent
The U.S. Supreme Court yesterday issued their anxiously awaited decision in a case that raised the issue of whether companies like Salt Lake City-based Myriad Genetics, Inc. can patent genes, in this case, the BRCA1 and BRCA2 genes. The Court ruled that naturally isolated DNA is not patentable, but that synthetic DNA (such as the cDNA for the BRCA1 and 2 genes) is patentable. Euan Ashley, assistant professor of cardiovascular medicine, is quoted in this article. The decision is also discussed in stories from MIT Technology review, which quotes Hank Greely; Wired.com, which quotes Drew Endy, assistant professor of bioengineering; and entries on the Stanford blog Scope, which feature Carlos Bustamante, professor of genetics, and Jake Sherkow, a fellow at the Stanford Center for Law and Biosciences.
Discover Magazine (July/August)
--Faroe Islands aim to sequence genes of entire country
The Faroe Islands is offering whole genome sequencing to every citizen who wants it. Hank Greely, with the Stanford Center for Biomedical Ethics (SCBE), provides comment in this magazine piece.
--Second child placed on adult transplant list
Debate over the age restriction for lung transplants intensifies, as a second child is temporarily placed on the waiting list for adult lung recipients. David Magnus, director of the Center for Biomedical Ethics at Stanford University, and Howard M. Nathan of the Gift of Life Donor program discuss
Science Friday (NPR)
This segment discussed the issue of genetic disclosures and just how much might be too much information for patients and doctors. Hank Greely, with the Stanford Center for Biomedical Ethics, and Kelly Ormond, director of the genetic counseling training program at Stanford, were featured on the program
--Bioethicists say criticisms of preemie oxygen study could have "chilling effect" on clinical research
The federal Office for Human Research Protections (OHRP) has decided to suspend sanctions it imposed earlier this year on a study of blood oxygen levels used to treat premature infants. Last week, a group of more than 40 of the country’s top bioethicists, including David Magnus, the Thomas A. Raffin Professor and director of the Stanford Center for Biomedical Ethics (SCBE), and Mildred Cho, professor of pediatrics and associate director of the SCBE, sent a letter to OHRP stating that the sanctions could have a chilling effect on much-needed clinical research
Today Show (NBC),
--A ten-year old girl is waiting for a lung transplant while struggling with cystic fibrosis. This segment discussed how national transplant rules don't allow children under the age of 12 to receive adult lungs. David Magnus, the Thomas A. Raffin Professor and director of the SCBE, was featured.
--On Monday the U.S. Supreme Court ruled that police may take DNA from people arrested in connection with serious crimes. Hank Greely, with the Stanford Center for Biomedical Ethics,
was interviewed during this segment
Los Angeles Times
--Supreme Court allows police to take DNA sample after an arrest
On Monday the U.S. Supreme Court ruled that police may take DNA from people arrested in connection with serious crimes. Hank Greely, with the Stanford Center for Biomedical Ethics (SCBE), provides comment in this story.